New York: While Type-2 diabetes is expected to rise by more than a fifth, from 406 million in 2018 to 511 million in 2030 globally, India along with China and the US will share over half of these high blood sugar cases, say researchers led by one of an Indian-origin, while asserting the need to improve access for the life saving insulin.
The study showed that China (130 million) followed by India (98 million), and the US (32 million) will constitute over half of Type-2 diabetics by 2030. As a result, the amount of insulin needed to effectively treat Type-2 diabetes will rise by more than 20 percent worldwide over the next 12 years. Compared to current levels of insulin access, if universal global access was achieved (with a treatment target of HbA1c — measure of blood glucose) seven per cent or lower, the number of people with Type-2 diabete worldwide using insulin in 2030 would double from around 38 million (7.4 per cent of all people with Type-2 diabetes) to 79 million (15.5 per cent), the researchers said.
“The number of adults with Type-2 diabetes is expected to rise over the next 12 years due to ageing, urbanisation, and associated changes in diet and physical activity. “Unless governments begin initiatives to make insulin available and affordable, then its use is always going to be far from optimal,” Basu said. Insulin is essential for all people with Type-1 diabetes and some people with Type-2 diabetes to reduce the risk of complications such as blindness, amputation, kidney failure, and stroke. (IANS)